BRIEF-Avita Medical says FDA approves continued access to ReCell in US burns trial

* US FDA approved continued access to ReCell, allowing US burns surgeons participating in co's regulatory trial to treat new patients using co's cell harvesting device
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.